In this context, aberrant ErbB signaling can also alter the tumor cells’ transcriptome, including the expression of tumor-associated antigens (TAA) and tumor-specific antigens (TSA), therefore influencing both the pool of processing peptides available for antigen presentation and the MHC repertoire present at the surface of tumor cells (152). This evidence concerns the gene HLA-C and neoplasm.